Table 2

Patient disposition

BimatoprostTravoprost
Patients randomised131 (100.0%)135 (100.0%)
Completed study127 (96.9%)132 (97.8%)
Discontinued4 (3.1%)3 (2.2%)
Reason for discontinuation
    Adverse event*2 (1.5%)0 (0.0%)
    Protocol violation1 (0.8%)1 (0.7%)
    Lost to follow-up0 (0.0%)2 (1.5%)
    Personal reason1 (0.8%)0 (0.0%)
  • *Adverse event could be related or unrelated to treatment.